C. Paglino

Oncology · 2014

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom C. Paglino trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Stockman

Papers from C. Paglino's perspective

Ordered by how strongly the researchers C. Paglino trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. (New England Journal of Medicine)
  2. Protein-protein interactions define specificity in signal transduction. (Genes & Development)
  3. The LKB1 tumor suppressor negatively regulates mTOR signaling. (Cancer Cell)
  4. AKT plays a central role in tumorigenesis (Proceedings of the National Academy of Sciences of the United States of America)
  5. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery (Nature reviews. Drug discovery)
  6. mTOR signaling in growth control and disease (Cell)
  7. Current development of mTOR inhibitors as anticancer agents (Nature reviews. Drug discovery)
  8. Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression (Cell Cycle)
  9. Upstream and downstream of mTOR. (Genes & Development)
  10. Everolimus for Advanced Pancreatic Neuroendocrine Tumors

Their papers